USE OF A COMBINATION OF MORPHINE AND AT LEAST ONE OPIATE ANTAGONIST FOR TREATMENT OF OPIATE DEPENDENCY AND FOR PREVENTION OF NON-ORAL OPIATE ABUSE IN OPIATE ADDICTS

摘要

Use of delayed-release morphine (I) and at least one opiate antagonist (II) that lacks high bioavailability after oral administration for preparation of a non-intravenously administered pharmaceutical composition for treating drug addiction. ACTIVITY : Antiaddictive. No details of tests for antiaddictive activity are given. MECHANISM OF ACTION : Opiate substitution and antagonism.